Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierNational and Kapodistrian University of Athens [NKUA]
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorBAKOYIANNIS, Ioannis
hal.structure.identifierNational and Kapodistrian University of Athens [NKUA]
dc.contributor.authorKITRAKI, Efthymia
hal.structure.identifierNational and Kapodistrian University of Athens [NKUA]
dc.contributor.authorSTAMATAKIS, Antonios
dc.date.accessioned2023-06-09T07:29:31Z
dc.date.available2023-06-09T07:29:31Z
dc.date.issued2021-09-01
dc.identifier.issn1521-690Xen_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/182605
dc.description.abstractEnEarly life exposure to endocrine-disrupting chemicals (EDCs) is considered a potential risk factor for aberrant brain development and the emergence of behavioral deficits. The purpose of this review is to summarize the toxic effects of bisphenol-A (BPA) and phthalate exposure during pre-, -post- or perinatal life on different types of behaviour in male and female rodents. Despite results not being always consistent, most probably due to methodological issues, it is highly probable that early life exposure to BPA or/and phthalates, affects various aspects of behaviour in the offspring. Adverse effects include: Increased levels of anxiety, altered exploratory behaviour, reduced social interaction or increased aggression and deficits in spatial or recognition learning and memory. These effects have been observed with a wide range of doses, in some cases even below the currently employed Tolerable Daily Intake dose for either BPA or phthalates.
dc.language.isoENen_US
dc.subject.enanxiety
dc.subject.enBPA
dc.subject.enendocrine disruptors
dc.subject.enmemory
dc.subject.enphthalate
dc.subject.ensocial behavior
dc.title.enEndocrine-disrupting chemicals and behaviour: A high risk to take?
dc.title.alternativeBest Practice & Research Clinical Endocrinology & Metabolismen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.beem.2021.101517en_US
dc.subject.halSciences du Vivant [q-bio]/Neurosciences [q-bio.NC]en_US
dc.identifier.pubmed33744126en_US
bordeaux.journalBest Practice & Research Clinical Endocrinology & Metabolismen_US
bordeaux.page101517en_US
bordeaux.volume35en_US
bordeaux.hal.laboratoriesNutriNeuro (Laboratoire de Nutrition et Neurobiologie Intégrée) - UMR 1286en_US
bordeaux.issue5en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINRAEen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Best%20Practice%20&%20Research%20Clinical%20Endocrinology%20&%20Metabolism&rft.date=2021-09-01&rft.volume=35&rft.issue=5&rft.spage=101517&rft.epage=101517&rft.eissn=1521-690X&rft.issn=1521-690X&rft.au=BAKOYIANNIS,%20Ioannis&KITRAKI,%20Efthymia&STAMATAKIS,%20Antonios&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée